BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22411123)

  • 1. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia.
    Bresolin S; Trentin L; Zecca M; Giordan M; Sainati L; Locatelli F; Basso G; te Kronnie G
    Leukemia; 2012 Jul; 26(7):1717-9. PubMed ID: 22411123
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
    Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
    Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.
    Patel LM; Maghari A; Schwartz RA; Kapila R; Morgan AJ; Lambert WC
    Int J Dermatol; 2012 Apr; 51(4):383-8. PubMed ID: 22435424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
    Rupniewska ZM
    Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndrome--its natural history, clinical course and diagnosis].
    Weryńska B
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):867-71. PubMed ID: 2487939
    [No Abstract]   [Full Text] [Related]  

  • 11. Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
    Feldman EJ
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):523-6. PubMed ID: 22127315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of secondary acute myeloid leukemia.
    Della Porta MG
    Leuk Res; 2013 Aug; 37(8):857-8. PubMed ID: 23664172
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
    Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
    Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: 2 new cases].
    Guillén M; Madero L; Parra L; Hernández C; Herrero B; Carceller F; Lassaletta A; Sevilla J
    An Pediatr (Barc); 2013 Jun; 78(6):393-7. PubMed ID: 23182617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
    Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
    J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
    Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
    Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.
    Pigazzi M; Manara E; Bresolin S; Tregnago C; Beghin A; Baron E; Giarin E; Cho EC; Masetti R; Rao DS; Sakamoto KM; Basso G
    Haematologica; 2013 Apr; 98(4):602-10. PubMed ID: 23100280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia.
    Bresolin S; Zecca M; Flotho C; Trentin L; Zangrando A; Sainati L; Stary J; de Moerloose B; Hasle H; Niemeyer CM; Te Kronnie G; Locatelli F; Basso G
    J Clin Oncol; 2010 Apr; 28(11):1919-27. PubMed ID: 20231685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.